About this episode

The episode discusses the implications of Kyle Diamantas's appointment at the FDA and the associated concerns regarding pharmaceutical company influence and drug safety.

The Nurses Report with Ashley, Nicole, & David – FDA leadership shifts as Kyle Diamantas steps into power, raising alarms over his past work defending pharmaceutical companies in Abilify litigation. The story connects Mirapex, hidden safety signals, sealed settlements, and regulatory failure, arguing that drug victims face impossible burdens while pharma profits from secrecy, influence, and institutional protection today...

People in this episode

Hosts: Ashley, Nicole, David

Topics covered

• FDA leadership
• pharmaceutical litigation
• drug safety
• regulatory failure
• pharma influence

Keywords

• FDA
• Kyle Diamantas
• pharmaceutical companies
• Abilify
• Mirapex
• drug safety
• regulatory failure

Mentioned in this episode

Organizations: FDA, pharmaceutical companies

Products: Abilify, Mirapex

More episodes of Corruption | America Out Loud News

• How the California machine protects itself – until it can’t · June 12, 2026 · 57 min
• SPLC indicted for alleged role in Charlottesville rally · June 11, 2026 · 57 min
• How for-profit hospitals impacted COVID-19 patient care · June 11, 2026 · 57 min
• Live by the bribe, die by the bribe · June 11, 2026 · 57 min
• Rigged – California: How laws, and ballots, shape the perception of election integrity · June 10, 2026 · 57 min
• Senate hearing links COVID-19 vaccines to cancer risks · June 10, 2026 · 57 min

Explore listener stats, chart rankings, contacts and more on the Corruption | America Out Loud News podcast page.